Evoke Pharma Inc Quarterly Entity Common Stock, Shares Outstanding from Q3 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Evoke Pharma Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2013 to Q3 2024.
  • Evoke Pharma Inc Entity Common Stock, Shares Outstanding for the quarter ending November 6, 2024 was 1.49M shares, a 55.6% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.49M -1.86M -55.6% Nov 6, 2024 10-Q 2024-11-07
Q2 2024 735K -2.61M -78% Aug 8, 2024 10-Q 2024-08-13
Q1 2024 8.48M +5.13M +154% Mar 1, 2024 10-K/A 2024-05-14
Q3 2023 3.34M 0 0% Nov 3, 2023 10-Q 2023-11-09
Q2 2023 3.34M 0 0% Aug 4, 2023 10-Q 2023-08-10
Q1 2023 3.34M -29.6M -89.8% Feb 28, 2023 10-K 2023-03-21
Q3 2022 3.34M -29.3M -89.8% Nov 4, 2022 10-Q 2022-11-09
Q2 2022 3.34M -29.1M -89.7% Aug 5, 2022 10-Q 2022-08-10
Q1 2022 32.9M +546K +1.69% Feb 28, 2022 10-K 2022-03-08
Q3 2021 32.7M +6.27M +23.7% Nov 1, 2021 10-Q 2021-11-10
Q2 2021 32.4M +6.43M +24.7% Jul 31, 2021 10-Q 2021-08-12
Q1 2021 32.4M +7.94M +32.5% Apr 30, 2021 10-Q 2021-05-12
Q3 2020 26.4M +2.16M +8.91% Nov 2, 2020 10-Q 2020-11-10
Q2 2020 26M +1.9M +7.87% Jul 31, 2020 10-Q 2020-08-06
Q1 2020 24.4M +1.17M +5.03% Feb 29, 2020 10-K 2020-03-12
Q3 2019 24.2M +6.8M +39% Oct 31, 2019 10-Q 2019-11-07
Q2 2019 24.1M +7.22M +42.7% Jul 31, 2019 10-Q 2019-08-08
Q1 2019 23.3M +7.77M +50.1% Apr 30, 2019 10-Q 2019-05-08
Q3 2018 17.4M +2.01M +13.1% Oct 31, 2018 10-Q 2018-11-13
Q2 2018 16.9M +1.51M +9.82% Aug 3, 2018 10-Q 2018-08-09
Q1 2018 15.5M +105K +0.68% Feb 28, 2018 10-K 2018-03-07
Q3 2017 15.4M +3.06M +24.8% Nov 3, 2017 10-Q 2017-11-14
Q2 2017 15.4M +3.04M +24.6% Aug 4, 2017 10-Q 2017-08-14
Q1 2017 15.4M +8.15M +113% Mar 10, 2017 10-K 2017-03-15
Q3 2016 12.4M +5.2M +72.8% Nov 4, 2016 10-Q 2016-11-09
Q2 2016 12.4M +6.01M +94.8% Aug 9, 2016 10-Q 2016-08-15
Q1 2016 7.24M +972K +15.5% Apr 30, 2016 10-Q 2016-05-11
Q3 2015 7.15M +1.04M +16.9% Oct 31, 2015 10-Q 2015-11-12
Q2 2015 6.34M +239K +3.92% Jul 31, 2015 10-Q 2015-08-13
Q1 2015 6.27M +169K +2.78% Apr 30, 2015 10-Q 2015-05-14
Q3 2014 6.11M +15.3K +0.25% Oct 31, 2014 10-Q 2014-11-13
Q2 2014 6.1M Aug 1, 2014 10-Q 2014-08-13
Q1 2014 6.1M Mar 20, 2014 10-K 2014-03-25
Q3 2013 6.1M Oct 31, 2013 10-Q 2013-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.